Bayer

(IN BRIEF) Bayer has officially opened a modern laboratory in Darmstadt, Germany, designed to accelerate research and development in phytomedicines and biotics, with a particular focus on Iberogast and future plant-based health innovations. The facility will enable rapid prototyping, foster … Read the full press release →

(IN BRIEF) Selex Gruppo Commerciale has signed a renewable energy purchase agreement with Iberdrola for 1,250 GWh of photovoltaic power, equal to 125 GWh annually from plants with 77 MW of capacity starting in July 2026. The PPA features a … Read the full press release →

(IN BRIEF) Covestro has appointed Annie Chen as the new Managing Director of Covestro Taiwan, effective 1 September 2025. Currently Head of Supply Chain and Logistics for Taiwan, Korea, New Zealand, and Australia, Chen succeeds Dr. Carsten Wildebrand, who will … Read the full press release →

(IN BRIEF) Bayer has filed for EU approval of icafolin‑methyl, its first new herbicide mode of action in over 30 years, after earlier submissions in Brazil, the U.S., and Canada. With peak sales estimated at €750 million, icafolin‑methyl is slated for … Read the full press release →

(IN BRIEF) ABN AMRO has nominated veteran executive Daniel Hartert to its Supervisory Board for a four‑year term, replacing Arjen Dorland. The appointment, subject to European Central Bank approval, will be decided at an EGM on 11 September 2025, with details posted at … Read the full press release →

(IN BRIEF) Bayer and M2i Group have extended their distribution partnership to cover Asia-Pacific, Latin America, and the United States, following a successful 2023 agreement in Europe and Africa. This exclusive deal will enable Bayer to market M2i’s pheromone gel … Read the full press release →

(IN BRIEF) Iberdrola España and Renfe have signed a 10-year VPPA to supply 370 GWh per year of onshore wind energy—equivalent to a 190 MW wind farm—granting Renfe long-term price stability and advancing Spain’s green transition. The pact will cut … Read the full press release →

(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release →

(IN BRIEF) Sanofi and Sobi have renewed their partnership with the World Federation of Hemophilia (WFH) to support the WFH Humanitarian Aid Program for up to five years. The new agreement includes the donation of up to 100 million international … Read the full press release →

(IN BRIEF) Borealis and Hosokawa Alpine have successfully developed MDO films using BorShape™ polyethylene that are thinner than industry norms—just 15 microns compared to the standard 23—without compromising mechanical strength or process stability. Tested in early 2025, these films offer … Read the full press release →

(IN BRIEF) Bayer has opened a new maize seed facility in Kabwe, Zambia, with a 32-million-euro investment that triples its current production capacity. The facility, part of Bayer’s growth strategy in Africa, is expected to provide high-yielding maize seeds to … Read the full press release →

(IN BRIEF) A collaborative study led by Bayer and Hurdle, in partnership with top academic institutions including the University of Birmingham and the University of Edinburgh, has introduced and validated InflammAge—a novel, non-invasive saliva-based biomarker that quantifies systemic chronic inflammation, … Read the full press release →

(IN BRIEF) Sanofi’s Dupixent has been granted FDA priority review for the treatment of bullous pemphigoid (BP), a chronic skin disease. If approved, Dupixent would be the first targeted medicine for BP in the U.S., with the FDA’s decision expected … Read the full press release →

(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising solutions for more precise evaluations, enabling targeted interventions such as aspirin therapy, which … Read the full press release →